Gen Z Consumers Are Obsessed with Fragrances, Boosting Sales for Coty and Estee.
Fragrance Popularity Among Gen Z: Fragrances have become a key product for Gen Z shoppers, who are increasingly using scents to express their style and improve their mood during economic uncertainty, reflecting the "lipstick effect" where consumers opt for small luxuries instead of larger purchases.
Investment by Major Brands: Major beauty companies like Estee Lauder, L'Oréal, and Coty are significantly investing in their fragrance lines, which have become primary sales drivers, with Coty forecasting growth due to rising demand for its fragrance brands.
Market Trends and Sales Growth: Data indicates that 38% of fragrance spending comes from households with Gen Z members, and global fragrance sales growth has outpaced that of makeup and skincare, with prestige fragrance sales increasing by 6% in the first half of 2025.
Strategic Acquisitions and Innovations: Companies are expanding their fragrance portfolios through acquisitions, such as L'Oréal's $4.7 billion deal for Kering's brands, while also leveraging technology and social media to engage younger consumers, including the use of AI to connect scent descriptions with consumer preferences.
Trade with 70% Backtested Accuracy
Analyst Views on COTY
About COTY
About the author

- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit representing investors who purchased stock between November 5, 2025, and February 4, 2026, following its Q2 2026 earnings report that revealed serious operational issues, causing an over 8% drop in share price on the announcement day.
- Executive Departure: The abrupt departure of CEO Sue Y. Nabi on December 12, 2025, without explanation, has raised concerns regarding corporate governance and transparency, exacerbating investor anxiety about the company's future.
- Deteriorating Financial Performance: The Q2 2026 report indicated that Coty's Consumer Beauty segment's operating income plummeted over 70% year-over-year, while Prestige fragrance income fell by 18%, highlighting significant challenges in market competitiveness.
- Investor Confidence Eroded: Coty withdrew its FY 2026 EBITDA and free cash flow guidance, with management projecting mid-single-digit revenue declines for Q3, indicating uncertainty regarding the company's profitability and market outlook moving forward.
- Legal Challenges: Coty is facing a lawsuit from DB Ventures for severe breaches of the licensing agreement, with allegations of mismanagement leading to David Beckham fragrances being sold at gas stations, which damages brand reputation and exacerbates challenges in Coty's fragrance business.
- Revenue Decline Risks: While Coty's fragrance segment is its primary revenue driver, it is shrinking due to the impending loss of Gucci's license and intensified competition, with third-quarter adjusted EBITDA expected to fall to $100-$110 million, significantly below analysts' average forecast of $201.6 million.
- Stock Price Plunge: Coty's shares have plummeted 78% over the past year, hitting a record low in early April, placing interim CEO Markus Strobel under pressure to revitalize the company, especially with the anticipated loss of the lucrative Gucci brand.
- Strategic Review Initiatives: Coty has launched a strategic review of its consumer cosmetics business, assessing options such as partnerships, divestitures, and spin-offs for brands like Rimmel and Max Factor, aiming to restore sales growth by focusing on core brands.
- Legal Action Reminder: Faruq & Faruqi LLP is investigating potential claims against Coty Inc., specifically for investors who purchased or acquired securities between November 5, 2025, and February 4, 2026, urging them to seek lead plaintiff status by the May 22, 2026 deadline to protect their legal rights.
- Investor Loss Focus: Securities Litigation Partner Josh Wilson encourages affected investors to contact him directly, providing two phone numbers to help them understand their legal options and seek potential compensation, demonstrating a commitment to investor rights.
- Firm Background: Founded in 1995, Faruqi & Faruqi is a leading national securities law firm that has recovered hundreds of millions of dollars for investors, showcasing its expertise and successful track record in securities litigation.
- Legal Consultation Channels: Investors can reach out to Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) or visit the firm's website for more information, ensuring they receive timely legal support.
- Class Action Filed: Pomerantz LLP has initiated a class action lawsuit against Coty, alleging securities fraud and other unlawful business practices by the company and certain officers, with investors urged to apply as Lead Plaintiff by May 22, 2026, indicating significant investor dissatisfaction with corporate governance.
- Disappointing Earnings Report: Coty's financial results for Q2 FY 2026, announced on February 4 and 5, revealed worsening performance in the Consumer Beauty segment, leading the company to withdraw its EBITDA guidance for FY 2026, reflecting macroeconomic pressures and uncertain consumer demand.
- Stock Price Plunge: Following the earnings report, Coty's stock price fell by $0.77, or 22.45%, over two trading sessions, closing at $2.66, demonstrating market pessimism regarding the company's future outlook.
- CEO Transition Impact: The recent transition of Coty's CEO, coupled with disappointing results, highlights a lack of
- Lawsuit Background: Coty Inc. is facing a class action lawsuit for allegedly making false statements regarding its performance between November 5, 2025, and February 4, 2026, claiming that the company misrepresented its slowing growth and compressed margins in the beauty market, potentially leading to investor losses.
- Investor Rights: Affected investors must file to become lead plaintiffs by May 22, 2026, with lead plaintiffs representing other shareholders in the litigation, although absent shareholders can still share in any recovery without participating directly.
- Legal Fee Arrangement: Bernstein Liebhard LLP offers a no-risk representation for participating shareholders, with all fees and expenses covered by the law firm, ensuring that investors do not incur additional costs in the legal proceedings.
- Law Firm Background: Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for clients and has been recognized multiple times as a leading law firm in investor rights protection, highlighting its expertise in class action litigation.
- Lufax Lawsuit Overview: Lufax Holding Ltd. faces a class action for the period from April 7, 2023, to January 26, 2025, due to undisclosed internal control deficiencies and misstated financial results, with a lead plaintiff deadline of May 20, 2026, potentially impacting the company's reputation and stock price.
- Atara Biotechnology Issues: Atara Biotherapeutics, Inc. is involved in a class action for the period from May 20, 2024, to January 9, 2026, alleging undisclosed manufacturing issues and clinical trial risks that overstated FDA approval prospects, with a lead plaintiff deadline of May 22, 2026, likely to have a significant negative impact on the company's financial condition.
- Coty Performance Decline: Coty Inc. is facing a class action for the period from November 5, 2025, to February 4, 2026, due to undisclosed underperformance in its Consumer Beauty segment and slowing market growth, with a lead plaintiff deadline of May 22, 2026, which may affect the company's future market performance.
- Legal Consultation Opportunity: Investors are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights and explore participation in these class actions, indicating that the legal risks faced by these companies could impact shareholder confidence and market performance.











